Polymorphous forms of rifaximin as antibiotics

Details for Australian Patent Application No. 2004287601 (hide)

Owner Alfa Wassermann S.p.A.

Inventors Braga, Dario; Viscomi, Giuseppe C.; Righi, Paolo; Campana, Manuela; Confortini, Donatella; Rosini, Goffredo; Cannata, Vincenzo

Agent Lord and Company

Pub. Number AU-B-2004287601

PCT Pub. Number WO2005/044823

Priority MI2003A002144 07.11.03 IT

Filing date 4 November 2004

Wipo publication date 19 May 2005

Acceptance publication date 26 February 2009

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/4188 (2006.01)

A61K 31/4353 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/437 (2006.01)

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 498/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/044823 Priority application(s): WO2005/044823

26 February 2009 Application Accepted

  Published as AU-B-2004287601

5 March 2009 Corrigenda

  Applications Accepted - Name Index Under the name Alfa Wassermann S.p.A., Application No. 2004287601, under INID(54), correct the invvention title to Polymorphous forms of rifaximin, processes for their production and use thereof in medical preparations Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2003203724 Matsushita Electric Industrial Co., Ltd. 2004212842 Otsuk

25 June 2009 Standard Patent Sealed

25 June 2009 Corrigenda

  Applications Accepted - Name Index Under the name Alfa Wassermann S.p.A., Application No. 2004287601, under INID (54) correct the title to read Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations

2 August 2012 Extension of Term of Standard Patents

  Alfa Wassermann S.p.A. The earliest first regulatory approval date provided by the patentee 17 May 2012 For the goods XIFAXAN rifaximin Applications Accepted The following application(s) for Extension of Term have been accepted under Section 74. Notice of opposition under Section 75(1) to the undermentioned application(s) for an extension of term may be filed at the Patent Office within the prescribed time.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004287605-Fixing device for a module on the surface of a tyre

2004287599-Security document, method for producing a security document and the use of a security element